I am BIO Podcast

Powerful stories of biotech breakthroughs, the people they help, and the global problems they solve.

Episode 66  •  Nov 29, 2022  •  25 min
Let’s Get Uncomfortable: Talking About Women’s Health
Episode Topic:

Talking about women’s health has been a taboo subject for some time, contributing to a lack of innovation in the sector. Still today, many are uncomfortable discussing the topic. Consequently, only 2% of medical products in the pipeline are for women’s health and only 2% of all venture capital dollars go into developing these products. In this episode, we talk with two women in biotech who are trying to change that narrative and infuse more investment in innovations that meet the needs of half the population.


Episode Guests
Sabrina Martucci Johnson
CEO, Daré Bioscience
Elizabeth Bailey
Managing Director, RH Capital
Recommended Episodes
Biotech Women Striking at the Glass Ceiling
Episode 76  •  Oct 3, 2023  •  24 min

The biotech industry offers unique opportunities for women to advance as executives and entrepreneurs. There are headwinds, however, including unequal access to venture capital. In this episode, we talk with three executives who are part of a wave of women-led companies in biotech. Our guests speak to why women’s leadership matters and the barriers that remain to breaking the glass ceiling. They also tell us about a new networking initiative—the biotech sisterhood—to catalyze women’s success in corporate leadership and mentor the next generation of women executives. 

Read More
Cracking the Code on Pain Relief
Episode 67  •  Feb 28, 2023  •  26 min

Imagine living with excruciating pain that prevents you from walking or doing the things most of us take for granted. We all experience pain, and 50 million people cope with chronic, debilitating pain. The market for pain therapies is estimated at $74 billion. And yet, investment in new pain and addiction treatments is falling short of what is needed, according to a new BIO report, which shows a 44% decrease in clinical drug programs for pain over the past five years. Our guests on this episode talk about the challenges of living with and treating pain, as well as research and development on new, non-addictive and safer pain therapies.

Read More
Investors Become Goldilocks in a Bear Market
Episode 60  •  May 31, 2022  •  25 min

Current market trends have put investors in a “flight-to-safety” mentality, especially when it comes to biotech companies. What does this mean for getting biotech innovations to the marketplace? This episode explores the daunting challenge of raising capital in a bear market.

Read More

Contact us

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.